Quantcast
Free Trial!
Today’s Best Stocks To Trade!  Click Here


 

BUYINS.NET: PFB, GGR, ACOR, BKHM, BPFH, BRLC Have Been Removed From Naked Short List Today

Tue. July 22, 2008; Posted: 09:31 AM
Stocks RSS
7 Stocks You Need To Know For Tomorrow -- Free Newsletter
Jul 22, 2008 (M2 PRESSWIRE via COMTEX) -- PFB | Quote | Chart | News | PowerRating -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list: PFF Bancorp Inc. (NYSE: PFB), GeoGlobal Resources Inc (AMEX: GGR), Acorda Therapeutics Inc. (NASDAQ: ACOR), Bookham Inc (NASDAQ: BKHM), Boston Private Financial Holdings Inc. (NASDAQ: BPFH), SyntaxBrillian Corp. (NASDAQ: BRLC). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.

PFF Bancorp Inc. (NYSE: PFB | Quote | Chart | News | PowerRating) operates as a holding company for PFF Bank & Trust that provides community banking services to individuals and companies in Southern California. Its deposit products include passbook accounts, interest-bearing and non-interest bearing demand accounts, time and savings deposits, money market savings accounts, and variable-rate and step-up certificate accounts. The company's portfolio of loans include residential tract construction and land loans, commercial real estate loans, real estate equity based consumer loans, one-to-four family residential mortgage loans, multi-family residential and mortgage loans, and commercial business loans. As of March 31, 2008, it operated 38 full service banking branch offices in Los Angeles, San Bernardino, Riverside, and northern Orange counties. The company, through its other subsidiaries, provides wealth management and advisory services to high net worth individuals and businesses; and provides financing and consulting services to home builders and land developers. It also offers financing services, including real estate consulting, property entitlement, surety bond placement, loan and equity placement, and opportunity and mezzanine lending to home builders, commercial property owners, and land developers; and investment and asset management services to individuals and institutions, such as foundations and endowments, pension plans, and charitable organizations. In addition, the company sells various personal and business insurance policies, fixed and variable annuities, and mutual funds; provides cash management; owns business trusts for the purpose of issuing capital securities; and engages in real estate brokerage and property management activities. PFF Bancorp, Inc. was founded in 1892 and is headquartered in Rancho Cucamonga, California. With 22.62 million shares outstanding and 4.78 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of PFB. According to quarterly data provided by the SEC, there were still 12,935 shares of PFB that were failing-to-deliver as of September 11, 2007.

GeoGlobal Resources Inc (AMEX: GGR | Quote | Chart | News | PowerRating) a development stage company, through its subsidiaries, engages in the exploration and development of oil and natural gas reserves primarily in India. The company is headquartered in Calgary, Canada. With 72.21 million shares outstanding and 2.4 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of GGR. According to quarterly data provided by the SEC, there were still 186,834 shares of GGR that were failing-to-deliver as of September 28, 2007.

Acorda Therapeutics Inc. (NASDAQ: ACOR | Quote | Chart | News | PowerRating) a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions in people with multiple sclerosis (MS), spinal cord injury, and other disorders of the central nervous system in the United States. It markets Zanaflex Capsules and Zanaflex tablets, a short-acting drug indicated for the management of spasticity. The company's lead product candidate is Fampridine-SR, which is in a Phase III development for the improvement of walking ability in patients with MS. Its preclinical programs comprise remyelination programs that include two distinct therapeutic approaches to stimulate repair of the damaged myelin sheath in MS, Glial Growth Factor 2, or GGF-2, and remyelinating antibodies; and Chondroitinase Program that develops second generation approaches to overcoming the proteoglycan matrix. Acorda Therapeutics sells its products through internal specialty sales force and contract pharmaceutical telesales organizations. The company was founded in 1995 and is based in Hawthorne, New York. With 32.66 million shares outstanding and 7.63 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of ACOR. According to quarterly data provided by the SEC, there were still 22,919 shares of ACOR that were failing-to-deliver as of September 20, 2007.

Bookham Inc (NASDAQ: BKHM | Quote | Chart | News | PowerRating) designs, manufactures, and markets optical components, modules, and subsystems that generate, detect, amplify, combine, and separate light signals principally for use in fiber optics telecommunications networks. Its products include transmitters, transceivers, tunable lasers and transmitter modules, receivers, amplifiers, pump laser chips, transponder modules, and thin film filters. The company markets its optical component products to telecommunications systems vendors, as well as to customers in the data communications, military, aerospace, industrial, and manufacturing industries. Bookham, Inc. also designs, manufactures, markets, and sells photonics and microwave solutions. These solutions primarily include advanced photonic tools principally used for generating, measuring, moving, manipulating, modulating, and detecting optical signals; and tunable lasers for test and measurement applications. Its photonics and microwave product customers include academic, military, and governmental research institutions, and semiconductor capital equipment manufacturers. The company sells its products and services through direct sales force, international sales representatives, resellers, and catalogs in the United Kingdom, the People's Republic of China, France, Germany, Switzerland, Canada, Italy, and the United States. Bookham, Inc. was founded in 1988 and is headquartered in San Jose, California. With 100.74 million shares outstanding and 1.02 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of BKHM. According to quarterly data provided by the SEC, there were still 26,982 shares of BKHM that were failing-to-deliver as of September 26, 2007.

Boston Private Financial Holdings Inc. (NASDAQ: BPFH | Quote | Chart | News | PowerRating) operates as the multi-bank holding company in the United States. It provides private banking, investment management, and wealth advisory services to high net worth individuals, families, businesses, and select institutions. The company offers various deposit products that include checking accounts, demand deposits, NOW accounts, savings accounts, money market accounts, and certificate of deposits. Its loan portfolio comprises residential mortgage loans, and mortgage loans on investment and vacation properties to individuals; unsecured and secured personal lines of credit, home equity loans, and overdraft protection; commercial construction and mortgage loans; revolving lines of credit; working capital loans; equipment financing; and letters of credit. In addition, Boston Private Financial Holdings offers financial planning, tax planning, investment management, asset allocation, estate and insurance planning, retirement planning, income tax planning, and charitable planning services. The company was founded in 1988 and is headquartered in Boston, Massachusetts. With 38.51 million shares outstanding and 11.1 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of BPFH. According to quarterly data provided by the SEC, there were still 62,438 shares of BPFH that were failing-to-deliver as of September 26, 2007.

SyntaxBrillian Corp. (NASDAQ: BRLC | Quote | Chart | News | PowerRating) is one of the world's leading manufacturers and marketers of LCD HDTVs, digital cameras, and consumer electronics products. The Company's lead products include its Olevia(TM) brand (www.Olevia.com) high-definition widescreen LCD televisions -- one of the fastest growing global TV brands -- and Vivitar brand (www.vivitar.com) digital still and video cameras. Syntax-Brillian has built an Asian supply chain coupled with an international manufacturing and distribution network to support worldwide retail sales channels and position the Company as a market leader in consumer digital entertainment products. With 93.35 million shares outstanding and 12.29 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of BRLC. According to quarterly data provided by the SEC, there were still 3,568,131 shares of BRLC that were failing-to-deliver as of September 28, 2007.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,050,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on Acorda Therapeutics Inc (ACOR) click here. Acorda Therapeutics Inc (ACOR) has Short Term PowerRatings of 5. Details on Acorda Therapeutics Inc (ACOR) Short Term PowerRatings is available at This Link.
Morning Coffee with TradingMarkets -- Free Newsletter

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.